-
A Congress Member Sold Up To $65K In Bristol-Myers Squibb Stock: Here's What You Need To Know
2026 Jun 12, 11:00am | 305Read More...Records from June 11, 2026 indicate that Representative Mike Kelly of Pennsylvania made a sale of Bristol-Myers Squibb (NYSE:BMY), valued between $16,002 and $65,000, with the transaction dated May 7, 2026 and filed in June. As of now, Bristol-Myers Squibb shares are trading up 0.23% at $57.03....
-
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
2026 Jun 12, 10:47am | 550Read More...Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday’s session. On Thursday, the company highlighted follow-up data from its Phase 1 SANRECO study of divesiran. SLN Stock Catalyst: SANRECO Phase 1 Follow-Up Data Recent analyses from the Phase 1 SANRECO study show potential...
-
MBX Biosciences Highlights Sustained Calcium Control In Rare Disease
2026 Jun 12, 10:43am | 603Read More...MBX Biosciences Inc. (NASDAQ:MBX) on Thursday reported full results from its 12-week Avail Phase 2 trial and new one-year data from an ongoing open-label extension study of once-weekly canvuparatide in adults with chronic hypoparathyroidism. Hypoparathyroidism is a rare condition in which the...
-
SpaceX IPO: First Indicative Price At $174 Per Share
2026 Jun 12, 10:36am | 687Read More...Space Exploration Technologies Corp. (NASDAQ:SPCX) is indicating an opening price of $174 per share Friday morning, according to data compiled by the Benzinga Pro platform, as the most anticipated public offering in history begins trading on the Nasdaq Global Select Market. That’s a nearly 29...
-
AbbVie Says Nine-Year Data Reinforces Venetoclax Benefit In Leukemia Patients
2026 Jun 12, 10:30am | 643Read More...AbbVie Inc. (NYSE:ABBV) stock is up slightly on Friday on new data presented at the European Hematology Association (EHA) 2026 Congress. The company unveiled results from the Phase 3 CLL14 trial involving its venetoclax-based therapy for chronic lymphocytic leukemia (CLL). New Venetoclax Data At...
-
Why Is Climb Bio Stock Gaining Friday?
2026 Jun 12, 10:19am | 884Read More...Climb Bio Inc. (NASDAQ:CLYM) on Thursday shared initial data from its ongoing Phase 1b portion of its Phase 1b/2a study of budoprutug for primary immune thrombocytopenia (ITP), an autoimmune disorder where the immune system mistakenly attacks and destroys platelets. The data show a favorable safety...
-
SpaceX Isn't Meta, It's Amazon, Says Investor Eyeing The IPO
2026 Jun 12, 10:10am | 624Read More...The comparisons are inevitable. As Space Exploration Technologies Corp (NASDAQ:SPCX), aka SpaceX, begins trading, some investors are pointing to Meta Platforms, Inc‘s (NASDAQ:META) rocky public debut as a cautionary tale for one of the most anticipated IPOs in years. Nancy Tengler, CEO and...
-
CoreWeave, Astera Labs, Nebius Group, And Others Added To Nasdaq-100: A 'Big Deal,' Says Jim Cramer
2026 Jun 12, 8:46am | 980Read More...Financial markets are actively buzzing as CoreWeave Inc. (NASDAQ:CRWV), Astera Labs Inc. (NASDAQ:ALAB), Nebius Group NV (NASDAQ:NBIS), Rocket Lab Corp. (NASDAQ:RKLB), and Teradyne Inc. (NASDAQ:TER) are officially set to join the prestigious Nasdaq-100 Index this month. This quarterly reconstitution...
-
'Programmed For War': Why SpaceX Bulls Are Betting On Elon Again
2026 Jun 12, 8:08am | 596Read More...As investors debate whether SpaceX‘s blockbuster IPO is priced for perfection, Nancy Tengler says they’re asking the wrong question. The CEO and CIO of Laffer Tengler Investments argues that SpaceX isn’t the kind of company investors buy for near-term earnings projections or...
-
Trump Gets Mighty Praise From 'Farmers Of The Sea' After Reopening 500,000 Square Miles Of Pacific Waters For US Fishermen: 'You're One Of Us Now…'
2026 Jun 12, 8:01am | 659Read More...President Donald Trump on Thursday signed a proclamation reopening nearly 500,000 square miles of protected Pacific waters to commercial fishing, restoring access to key marine zones as part of his "America First Fishing Policy." The White House said the move restores commercial fishing access to...
-
Trump Pushes To Expunge His Impeachments As Experts Call The Plan 'Absurd:' Report
2026 Jun 12, 5:40am | 520Read More...President Donald Trump and his allies are reportedly working to expunge his two impeachments from the congressional record, a move constitutional experts say Congress has no power to make. Congress Has No Such Power The effort would have little legal significance, The Wall Street Journal reported,...
-
SpaceX-Linked Powerlaw Stock Is Popping In Pre-Market: Here's Why PWRL Is Surging
2026 Jun 12, 4:33am | 425Read More...Powerlaw Corp. (NASDAQ:PWRL) shares jumped 13.64% to $25 in the pre-market session on Friday. The surge in the pre-market hours follows a previous day gain of 13.99%, which closed the stock of the California-based closed-end management investment company at $22, according to Benzinga Pro data....
-
Crude Oil Slips Below $90—Yet These 4 Tanker Stocks Reach Top-Tier Momentum Zones
2026 Jun 12, 4:21am | 1040Read More...While global crude prices have retreated beneath the critical $90 per barrel support level, the underlying shipping market is telling a different story as four major oil tanker stocks simultaneously surge into top-tier momentum zones. Surging Into The Top 10% Momentum Despite Brent Crude falling to...
-
Aditxt (ADTX) Stock Surges Nearly 17% After Hours: Here's Why
2026 Jun 12, 3:17am | 500Read More...Aditxt Inc. (NASDAQ:ADTX) shares surged 16.92% to $0.015 in after-hours trading Thursday, extending a 29.73% intraday gain. The stock closed the regular session at $0.013, according to Benzinga Pro data. What You Should Know The move came alongside a Securities and Exchange Commission filing...
-
SAVE Plan Exit Rush Begins— But Millions Of Student Loan Borrowers Haven't Moved Yet
2026 Jun 12, 2:45am | 698Read More...More than 300,000 federal student loan borrowers have exited the defunct SAVE repayment plan in recent weeks, but millions remain at risk as deadlines approach. Nicholas Kent, a top official at the U.S. Department of Education, told CNBC on Thursday that borrowers still enrolled in the Biden-era...
















